A single- dose comparison of three slow-release theophylline oral preparations in healthy Thai volunteers

Asian Pacific Journal of Allergy and Immunology

Volumn 14, Issue 1, 1996, Pages 13-18

  Kanthawatana, Sukanya ^a   Tontayapiwat, Arunee ^a   Tonsuwannont, Wittaya ^a   Manorot, Maleeya ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; BRONCHODILATING AGENT; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SLOW RELEASE FORMULATION; THAILAND; XANTHIUM;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; THAILAND; THEOPHYLLINE;

EID: 0030410468     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Zwillich CW, Sutton FD, Neff TA, et al. Theophylline-induced seizures in adults : correlation with serum concentrations. Ann Intern Med 1975; 82 : 784-7.
2. Hendeles L, Beighley L, Richardson RH, et al. Frequent toxicity from intravenous aminophylline infusion in critically ill patients. Drug Intelligence Clin Pharm 1977; 11 : 12-8.
3. Hendeles L, Weinberger M, Milavetz G, et al. Food-induced "dose dumping" from a once-a-day theophylline products as a cause of theophylline toxicity. Chest 1985; 87 : 758-65.
4. Neijen HJ, Duiverman EJ, Graatsma BH, et al. Clinical and bronchodilating efficacy of controlled-release theophylline as a function of its serum concentrations in preschool children. J Pediatr 1985; 107 : 811-5.
5. Dasta J, Mirtallo JM, Altman M. Comparison of standard and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease. Am J Hosp Pharm 1979; 36 : 613-7.
6. Weinberger M, Hendeles L, Wong L, et al. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma. J Pediatr 1981; 99 : 145-52.
7. Tabachnik E, Scott P, Correia J, et al. Sustained-release theophylline : a significant advance in the treatment of childhood asthma. J Pediatr 1982; 100 : 489-2.
8. Leeds NH, Gal P, Purohit AA, et al. Effects of food on the bioavailability and pattern of release of a sustained-release theophylline tablet. Clin Pharmacol 1982; 22 : 196-200.
9. Jonkman JHG. Food interactions with sustained-release theophylline preparations. A review. Clin Pharmacokinet 1989; 16 : 162-79.
10. Vichayanon P, Aranyanark N, Visitsuntorn N, et al. Theophylline pharmacokinetics in Thai Children. Asian Pac J Allergy Immunol. 1994; 12 : 137-43.
11. Ellis ER, Koysooko R, Levy G. Pharmacokinetics of theophylline in children with asthma. Pediatrics 1976; 58 : 542-7.
12. Loughnan PM, Sitar DS, Olgilvie RI, et al. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr 1976; 88 : 874-9.
13. Baker JR, Moessner H, Gonzalez U, et al. Clinical relevance of the subsitution of different brands of sustained-release theophylline. J Allergy Clin Immunol 1988; 81 : 664-5.
14. Hill HD, Jolley ME, Wang CHJ, et al. Fluorescence polarization immunoassay (FPIA) for theophylline : clinical and reagent stability. Clin Chem 1981; 27 : 1086.
15. Hendeles L, Iafrate RP, and Weinberger M. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products. Clin Pharmacokinet 1984; 9 : 95-135.
16. Jenne J, Nagasawa H, McHugh R, et al. Decreased theophylline half-life in cigarette smokers. Life Sci 1975; 17 : 195-8.
17. Kappas A, Anderson KE, Conney AH, et al. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin Pharmacol Ther 1976; 20 : 643-53.
18. Hunt SN, Jusko WJ, Yurchak AM. Effect of smoking on theophylline disposition. Clin Pharmacol Ther 1976; 19 : 546.
19. Powerll JR, Thiercelin J, Vozeh S, et al. The influence of cigarette smoking and sex on theophylline disposition. Am Rev Respir Dis 1977; 116 : 17-23.
20. Hendeles L, Weinberger M, and Bighley L. Disposition of theophylline after a single intravenous infusion of amino-phylline. Am Rev Resp Dis 1978; 118 : 97-103.
21. Barr, WH. Summary report of FDA Pulmonary-Allergy Drugs Advisory Committee meeting, June 20, 1983, and recommendations regarding labelling and evaluation of theophylline controlled release products with 24-hour dosing claim (FDA, Washington, D.C., 1983).
22. Weinberger M. Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline. Ann Allergy 1986; 56 : 2-8.